marketcaparena
Search

    ELUT

    ELUTIA INC.

    Company overview

    Market capitalization
    —
    Employees
    25
    Latest publication
    2026-09-29
    About ELUTIA INC.

    Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women's Health and Cardiovascular. Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic scaffolds combined with local antibiotic delivery. The company provides SimpliDerm, a human acellular dermal matrix used in soft tissue reconstruction. It also offers ProxiCor for cardiac tissue repair for use as an intracardiac patch for repairs, such as atrial and ventricular septal defects and suture-line buttressing, and pledgets, as well as for pericardial closure to reconstruct the pericardium after heart surgery. In addition, the company provides Tyke, a thinner pliable matrix for the repair of pericardial structures for neonates and infants; as an epicardial for damaged or repaired cardiac structures; and as a patch material for cardiac defects, as well as VasCure, a patch material to repair or reconstruct the peripheral vasculature. The company sells its products directly to hospitals and other healthcare facilities through independent sales agents. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Gaithersburg, Maryland.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue2,427,000USD3,114,000USD3,271,000USD3,323,000USD6,263,000USD6,030,000USD5,468,000USD5,922,000USD
    Cost Of Revenue980,000USD1,312,000USD1,357,000USD1,470,000USD3,205,000USD3,573,000USD3,144,000USD3,181,000USD
    Gross Profit1,447,000USD1,802,000USD1,914,000USD1,853,000USD3,058,000USD2,457,000USD2,324,000USD2,741,000USD
    Research Development2,527,000USD1,973,000USD1,215,000USD1,088,000USD1,456,000USD905,000USD834,000USD778,000USD
    Selling General Administrative3,454,000USD4,091,000USD3,995,000USD3,519,000USD3,695,000USD3,871,000USD4,393,000USD4,521,000USD
    Selling And Marketing Expenses1,366,000USD1,480,000USD2,645,000USD1,601,000USD3,778,000USD3,031,000USD2,918,000USD2,989,000USD
    General And Administrative Expenses3,454,000USD———————
    Total Operating Expenses9,404,000USD7,544,000USD7,405,000USD6,208,000USD12,933,000USD10,379,000USD10,756,000USD12,971,000USD
    Operating Income-7,957,000USD-5,742,000USD-5,491,000USD-4,355,000USD-9,875,000USD-7,922,000USD-8,432,000USD-10,230,000USD
    Total Other Income Expense Net319,000USD-2,082,000USD-1,030,000USD3,980,000USD273,000USD3,997,000USD-627,000USD11,524,000USD
    Income Before Tax-7,638,000USD-7,824,000USD-6,521,000USD-375,000USD-9,602,000USD-3,925,000USD-9,059,000USD1,294,000USD
    Income Tax Expense8,000USD70,000USD-11,000USD8,000USD8,000USD8,000USD2,000USD8,000USD
    Net Income-7,646,000USD-7,469,000USD70,791,000USD-3,868,000USD-9,610,000USD-3,933,000USD-9,061,000USD1,286,000USD
    Net Income Applicable To Common Shares-7,646,000USD———————
    Interest Income—108,000USD358,000USD—————
    Interest Expense—108,000USD3,635,000USD265,000USD518,000USD1,085,000USD1,070,000USD1,129,000USD
    Net Interest Income—108,000USD358,000USD-265,000USD-518,000USD-1,085,000USD-1,070,000USD-1,129,000USD
    Tax Provision—70,000USD-11,000USD8,000USD8,000USD8,000USD2,000USD8,000USD
    Net Income From Continuing Ops—-7,894,000USD-6,510,000USD-383,000USD-9,610,000USD-3,933,000USD-9,061,000USD1,286,000USD
    Ebit—-5,742,000USD-5,491,000USD-110,000USD-9,084,000USD-2,840,000USD-7,989,000USD2,423,000USD
    Ebitda—-5,412,000USD-5,194,000USD618,000USD-8,192,000USD-1,972,000USD-7,126,000USD3,285,000USD
    Depreciation And Amortization—330,000USD297,000USD728,000USD892,000USD868,000USD863,000USD862,000USD
    Reconciled Depreciation—330,000USD297,000USD728,000USD892,000USD868,000USD863,000USD862,000USD
    Unclassified Operating Expenses————4,004,000USD2,572,000USD2,611,000USD4,683,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue12,293,000USD24,375,000USD24,745,000USD23,849,000USD47,390,000USD42,682,000USD42,901,000USD39,038,000USD
    Cost Of Revenue5,697,000USD13,668,000USD13,692,000USD12,210,000USD28,368,000USD22,121,000USD23,133,000USD23,093,000USD
    Gross Profit6,596,000USD10,707,000USD11,053,000USD11,639,000USD19,022,000USD20,561,000USD19,768,000USD15,945,000USD
    Research Development4,163,000USD3,785,000USD4,399,000USD7,727,000USD9,266,000USD5,954,000USD2,400,000USD2,481,000USD
    Selling General Administrative15,080,000USD18,659,000USD14,104,000USD16,051,000USD13,687,000USD10,641,000USD9,616,000USD—
    Selling And Marketing Expenses5,765,000USD12,546,000USD13,087,000USD17,850,000USD18,825,000USD17,565,000USD16,161,000USD—
    Total Operating Expenses25,008,000USD46,358,000USD41,579,000USD46,828,000USD42,054,000USD34,160,000USD28,177,000USD24,166,000USD
    Operating Income-18,412,000USD-35,651,000USD-30,526,000USD-35,189,000USD-23,032,000USD-13,599,000USD-8,409,000USD-8,221,000USD
    Interest Income400,000USD———————
    Interest Expense387,000USD4,779,000USD5,796,000USD5,118,000USD5,324,000USD5,633,000USD5,381,000USD5,519,000USD
    Net Interest Income400,000USD-4,779,000USD-5,796,000USD-5,282,000USD-5,324,000USD-5,633,000USD-5,381,000USD—
    Income Before Tax-15,858,000USD-54,122,000USD-41,221,000USD-36,148,000USD-24,777,000USD-21,799,000USD-11,909,000USD-11,540,000USD
    Income Tax Expense13,000USD7,000USD28,000USD34,000USD55,000USD26,000USD30,000USD26,000USD
    Tax Provision13,000USD7,000USD28,000USD34,000USD55,000USD26,000USD30,000USD—
    Net Income53,380,000USD-53,949,000USD-37,656,000USD-32,897,000USD-24,832,000USD-21,825,000USD-11,939,000USD-11,566,000USD
    Net Income From Continuing Ops-15,871,000USD-54,129,000USD-41,249,000USD-32,897,000USD-24,832,000USD-21,825,000USD-11,939,000USD—
    Ebit-18,412,000USD-49,343,000USD-35,425,000USD-31,030,000USD-19,453,000USD-16,166,000USD-6,528,000USD-6,021,000USD
    Ebitda-15,627,000USD-45,892,000USD-31,916,000USD-27,297,000USD-15,723,000USD-12,302,000USD-2,672,000USD-2,221,000USD
    Depreciation And Amortization2,785,000USD3,451,000USD3,509,000USD3,733,000USD3,730,000USD3,864,000USD3,856,000USD3,800,000USD
    Reconciled Depreciation2,785,000USD3,451,000USD3,748,000USD3,733,000USD3,730,000USD3,864,000USD3,856,000USD—
    Total Other Income Expense Net2,554,000USD-18,471,000USD-10,695,000USD-959,000USD-1,745,000USD-8,200,000USD-3,500,000USD-3,319,000USD
    Unclassified Operating Expenses—11,368,000USD9,989,000USD5,200,000USD———21,685,000USD
    Net Income Applicable To Common Shares———-32,897,000USD-24,832,000USD-25,335,000USD-11,939,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets43,649,000USD55,209,000USD62,350,000USD29,407,000USD33,849,000USD39,298,000USD36,127,000USD48,407,000USD
    Cash And Equivalents19,896,000USD———————
    Total Current Assets37,215,000USD48,591,000USD55,818,000USD18,378,000USD22,280,000USD30,017,000USD26,172,000USD37,318,000USD
    Other Current Assets1,378,000USD15,378,000USD2,271,000USD8,093,000USD1,090,000USD5,513,000USD1,986,000USD431,000USD
    Other Non Current Assets2,522,000USD———————
    Total Liabilities27,903,000USD———————
    Total Current Liabilities21,045,000USD23,725,000USD25,139,000USD41,334,000USD37,948,000USD36,851,000USD37,795,000USD39,678,000USD
    Other Current Liabilities685,000USD———————
    Total Stockholder Equity15,746,000USD22,527,000USD27,672,000USD-43,918,000USD-41,843,000USD-36,458,000USD-46,260,000USD-40,238,000USD
    Total Equity Including Noncontrolling Interest15,746,000USD———————
    Net Receivables1,438,000USD2,068,000USD14,580,000USD3,553,000USD7,447,000USD2,860,000USD7,036,000USD7,513,000USD
    Inventory2,649,000USD2,657,000USD2,617,000USD2,011,000USD5,243,000USD4,286,000USD3,911,000USD3,633,000USD
    Property Plant Equipment Net2,922,000USD5,358,000USD5,003,000USD4,619,000USD4,994,000USD1,857,000USD1,682,000USD1,966,000USD
    Intangible Assets990,000USD1,260,000USD1,529,000USD1,800,000USD6,575,000USD7,424,000USD8,273,000USD9,123,000USD
    Accounts Payable3,531,000USD9,685,000USD4,791,000USD13,872,000USD6,074,000USD4,516,000USD4,149,000USD5,073,000USD
    Retained Earnings-191,328,000USD-183,682,000USD-176,213,000USD-247,004,000USD-243,136,000USD-233,526,000USD-229,593,000USD-220,532,000USD
    Total Liab—32,682,000USD34,678,000USD73,325,000USD75,692,000USD75,756,000USD82,387,000USD88,645,000USD
    Other Current Liab—13,516,000USD19,993,000USD22,240,000USD27,719,000USD29,400,000USD31,936,000USD34,114,000USD
    Common Stock—44,000USD43,000USD42,000USD42,000USD41,000USD35,000USD34,000USD
    Capital Stock—44,000USD43,000USD42,000USD42,000USD41,000USD35,000USD34,000USD
    Cash—28,488,000USD36,350,000USD4,721,000USD8,500,000USD17,358,000USD13,239,000USD25,741,000USD
    Cash And Short Term Investments—28,488,000USD36,350,000USD4,721,000USD8,500,000USD17,358,000USD13,239,000USD25,741,000USD
    Net Debt—-22,396,000USD-32,408,000USD21,604,000USD19,741,000USD7,658,000USD11,497,000USD3,635,000USD
    Short Term Debt—524,000USD355,000USD5,222,000USD4,155,000USD2,935,000USD1,710,000USD491,000USD
    Short Long Term Debt Total—6,092,000USD3,942,000USD26,325,000USD28,241,000USD25,016,000USD24,736,000USD29,376,000USD
    Property Plant Equipment Gross—5,358,000USD5,286,000USD4,619,000USD4,994,000USD1,857,000USD2,316,000USD1,966,000USD
    Common Stock Shares Outstanding—42,998,504shares47,243,564shares45,492,271shares46,308,642shares42,913,111shares34,845,672shares35,520,938shares
    Non Current Assets Total—6,618,000USD6,532,000USD11,029,000USD11,569,000USD9,281,000USD9,955,000USD11,089,000USD
    Non Current Liabilities Total—8,957,000USD9,539,000USD31,991,000USD37,744,000USD38,905,000USD44,592,000USD48,967,000USD
    Non Current Liabilities Other—1,873,000USD2,828,000USD3,910,000USD4,692,000USD4,735,000USD5,490,000USD7,799,000USD
    Net Working Capital—24,866,000USD30,679,000USD-22,956,000USD-15,668,000USD-6,834,000USD-11,623,000USD-2,360,000USD
    Unclassified Non Current Liabilities—7,084,000USD6,711,000USD6,978,000USD11,682,000USD12,408,000USD16,499,000USD18,527,000USD
    Unclassified Equity—206,121,000USD203,799,000USD203,002,000USD201,209,000USD196,986,000USD183,263,000USD180,226,000USD
    Short Long Term Debt———5,000,000USD3,750,000USD2,500,000USD1,250,000USD—
    Long Term Debt———21,103,000USD21,370,000USD21,762,000USD22,603,000USD22,641,000USD
    Accumulated Other Comprehensive Income———0USD—0USD——
    Non Currrent Assets Other———4,610,000USD——6,505,000USD—
    Unclassified Current Liabilities———-5,000,000USD-3,750,000USD-2,500,000USD-1,250,000USD—
    Unclassified Non Current Assets——————-6,505,000USD—
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets62,350,000USD36,127,000USD43,428,000USD68,841,000USD67,170,000USD82,810,000USD44,772,000USD47,741,000USD
    Intangible Assets1,529,000USD8,273,000USD11,671,000USD15,069,000USD18,466,000USD21,865,000USD25,262,000USD—
    Other Current Assets10,271,000USD1,986,000USD2,165,000USD11,883,000USD1,485,000USD3,274,000USD1,545,000USD1,109,000USD
    Total Liab34,678,000USD82,387,000USD82,028,000USD73,874,000USD53,649,000USD61,979,000USD99,883,000USD91,147,000USD
    Total Stockholder Equity27,672,000USD-46,260,000USD-38,600,000USD-5,033,000USD13,521,000USD20,831,000USD-55,111,000USD-43,406,000USD
    Other Current Liab11,241,000USD31,936,000USD36,250,000USD41,009,000USD11,587,000USD11,368,000USD9,213,000USD4,643,000USD
    Common Stock43,000USD35,000USD23,000USD16,000USD13,000USD10,000USD1,000USD9,000USD
    Capital Stock43,000USD35,000USD23,000USD16,000USD13,000USD10,000USD1,000USD—
    Retained Earnings-176,213,000USD-229,593,000USD-175,644,000USD-137,988,000USD-105,091,000USD-80,259,000USD-56,938,000USD-44,999,000USD
    Cash36,350,000USD13,239,000USD19,276,000USD16,989,000USD30,393,000USD39,150,000USD2,482,000USD2,413,000USD
    Cash And Short Term Investments36,350,000USD13,239,000USD19,276,000USD16,989,000USD30,393,000USD39,150,000USD2,482,000USD2,413,000USD
    Total Current Assets55,818,000USD26,172,000USD31,253,000USD50,699,000USD47,428,000USD59,707,000USD18,446,000USD18,135,000USD
    Total Current Liabilities25,139,000USD37,795,000USD43,037,000USD42,615,000USD26,001,000USD26,779,000USD18,274,000USD13,345,000USD
    Net Debt-28,767,000USD11,497,000USD4,676,000USD8,459,000USD-7,156,000USD-8,515,000USD23,049,000USD79,972,000USD
    Short Term Debt4,755,000USD1,710,000USD3,596,000USD232,000USD12,827,000USD12,824,000USD5,919,000USD3,001,000USD
    Short Long Term Debt Total7,583,000USD24,736,000USD23,952,000USD25,448,000USD23,237,000USD30,635,000USD25,531,000USD82,385,000USD
    Net Receivables6,580,000USD7,036,000USD5,959,000USD17,587,000USD5,996,000USD7,166,000USD7,229,000USD7,200,000USD
    Inventory2,617,000USD3,911,000USD3,853,000USD4,240,000USD9,554,000USD10,117,000USD7,190,000USD7,459,000USD
    Accounts Payable9,143,000USD4,149,000USD3,191,000USD1,374,000USD1,582,000USD2,054,000USD2,492,000USD1,589,000USD
    Property Plant Equipment Net5,003,000USD1,682,000USD504,000USD565,000USD1,200,000USD1,162,000USD988,000USD870,000USD
    Property Plant Equipment Gross5,286,000USD2,316,000USD1,085,000USD3,073,000USD5,640,000USD5,522,000USD4,883,000USD—
    Common Stock Shares Outstanding45,942,787shares29,071,113shares18,160,822shares13,832,887shares10,444,767shares10,226,122shares10,667,075shares10,667,075shares
    Non Current Assets Total6,532,000USD9,955,000USD12,175,000USD18,142,000USD19,742,000USD23,103,000USD26,326,000USD29,606,000USD
    Non Current Liabilities Total9,539,000USD44,592,000USD38,991,000USD31,259,000USD27,648,000USD35,200,000USD81,609,000USD77,802,000USD
    Non Current Liabilities Other2,828,000USD5,490,000USD5,875,000USD6,043,000USD16,540,000USD16,633,000USD16,596,000USD—
    Net Working Capital30,679,000USD-11,623,000USD-11,784,000USD8,084,000USD21,427,000USD32,928,000USD172,000USD—
    Unclassified Non Current Liabilities6,711,000USD16,499,000USD12,760,000USD-5,087,000USD-16,540,000USD-16,633,000USD28,100,000USD77,802,000USD
    Unclassified Equity203,799,000USD183,263,000USD136,998,000USD132,923,000USD118,586,000USD181,329,000USD58,763,000USD1,584,000USD
    Short Long Term Debt—1,250,000USD3,321,000USD8,990,000USD15,572,000USD15,574,000USD5,919,000USD—
    Long Term Debt—22,603,000USD20,356,000USD24,260,000USD10,410,000USD17,811,000USD19,612,000USD—
    Non Currrent Assets Other—6,505,000USD-1USD2,508,000USD76,000USD76,000USD76,000USD28,736,000USD
    Unclassified Non Current Assets—-6,505,000USD——————
    Unclassified Current Liabilities—-1,250,000USD-3,321,000USD-8,990,000USD-15,572,000USD-15,574,000USD-5,919,000USD4,112,000USD
    Other Assets——1USD1USD—76,000USD1USD1USD
    Current Deferred Revenue——-275,000USD—5,000USD533,000USD650,000USD—
    Other Liab———6,043,000USD17,238,000USD17,389,000USD17,301,000USD—
    Net Tangible Assets———-20,102,000USD-4,945,000USD-1,034,000USD-80,373,000USD—
    Accumulated Other Comprehensive Income—————-80,259,000USD-56,938,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation679,000USD
    Stock Based Compensation1,836,000USD
    Change To Account Receivables296,000USD
    Change To Inventory-32,000USD
    Change To Liabilities-816,000USD
    Change In Working Capital340,000USD
    Operating Cash Flow-16,292,000USD
    Capital Expenditures-550,000USD
    Unclassified Investing Cash Flow425,000USD
    Investing Cash Flow-125,000USD
    Net Common Stock Issuance-86,000USD
    Unclassified Financing Cash Flow49,000USD
    Financing Cash Flow-37,000USD
    Change In Cash-16,454,000USD
    End Cash Flow19,896,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-7,469,000USD70,791,000USD-3,868,000USD-9,610,000USD-3,933,000USD-9,061,000USD1,067,000USD-28,360,000USD
    Depreciation330,000USD297,000USD279,000USD946,000USD868,000USD863,000USD862,000USD862,000USD
    Stock Based Compensation931,000USD872,000USD1,982,000USD1,149,000USD1,211,000USD1,208,000USD1,775,000USD2,711,000USD
    Other Non Cash Items1,375,000USD-81,190,000USD-5,235,000USD957,000USD-4,432,000USD810,000USD-9,718,000USD21,771,000USD
    Change To Account Receivables-836,000USD1,076,000USD-667,000USD-290,000USD283,000USD268,000USD175,000USD-1,502,000USD
    Change To Inventory-40,000USD-548,000USD239,000USD-957,000USD-375,000USD-278,000USD-518,000USD-63,000USD
    Change In Working Capital-2,998,000USD-15,584,000USD2,069,000USD-1,670,000USD-2,595,000USD-6,077,000USD4,362,000USD1,395,000USD
    Total Cash From Operating Activities-7,831,000USD-24,814,000USD-2,887,000USD-8,228,000USD-8,881,000USD-12,257,000USD-3,427,000USD-4,332,000USD
    Capital Expenditures-458,999USD-854,000USD-630,000USD-114,000USD-278,000USD-94,000USD-547,000USD-2,000USD
    Free Cash Flow-8,289,999USD-25,668,000USD-3,517,000USD-8,342,000USD-9,159,000USD-12,351,000USD-3,974,000USD-4,330,000USD
    Total Cashflows From Investing Activities-34,000USD79,581,000USD-630,000USD-114,000USD-278,000USD-94,000USD-547,000USD182,000USD
    Total Cash From Financing Activities3,000USD-23,138,000USD-262,000USD-516,000USD13,278,000USD-151,000USD11,527,000USD9,787,000USD
    Issuance Of Capital Stock0USD-1,000USD0USD0USD13,796,000USD0USD-70,000USD12,460,000USD
    Change In Cash-7,862,000USD31,629,000USD-3,779,000USD-8,858,000USD4,119,000USD-12,502,000USD7,553,000USD5,637,000USD
    Begin Period Cash Flow36,350,000USD4,721,000USD8,500,000USD17,358,000USD13,239,000USD25,741,000USD18,188,000USD12,551,000USD
    End Period Cash Flow28,488,000USD36,350,000USD4,721,000USD8,500,000USD17,358,000USD13,239,000USD25,741,000USD18,188,000USD
    Other Cashflows From Investing Activities-34,000USD-462,000USD-1,022,000USD—-278,000USD—-560,000USD180,000USD
    Other Cashflows From Financing Activities-44,000USD-73,000USD-294,000USD-419,000USD-518,000USD949,000USD-1,262,000USD-791,000USD
    Net Borrowings—-23,064,000USD0USD0USD0USD0USD0USD—
    Unclassified Investing Cash Flow—80,897,000USD1,652,000USD———1,107,000USD—
    Investments——-630,000USD-114,000USD-278,000USD-94,000USD-547,000USD182,000USD
    Unclassified Operating Cash Flow——1,886,000USD———-1,775,000USD-2,711,000USD
    Sale Purchase Of Stock———-97,000USD————
    Unclassified Financing Cash Flow—————-1,100,000USD12,859,000USD-1,882,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income53,380,000USD-53,949,000USD-37,656,000USD-32,897,000USD-24,832,000USD-21,825,000USD-11,939,000USD-11,566,000USD
    Depreciation1,174,000USD3,667,000USD3,725,000USD3,733,000USD3,730,000USD3,864,000USD3,856,000USD3,800,000USD
    Stock Based Compensation4,397,000USD7,891,000USD2,437,000USD3,647,000USD3,535,000USD779,000USD208,000USD—
    Other Non Cash Items-85,040,000USD15,643,000USD661,000USD-1,628,000USD-254,000USD6,223,000USD1,117,000USD9,023,000USD
    Change To Account Receivables-2,000USD527,000USD802,000USD-14,647,000USD1,170,000USD64,000USD-30,000USD-1,611,000USD
    Change To Inventory-1,641,000USD-58,000USD-609,000USD-498,000USD563,000USD-2,927,000USD269,000USD1,099,000USD
    Change In Working Capital-18,734,000USD4,091,000USD9,072,000USD5,711,000USD2,375,000USD-2,667,000USD-467,000USD1,378,000USD
    Total Cash From Operating Activities-44,810,000USD-22,657,000USD-21,761,000USD-21,434,000USD-15,446,000USD-13,626,000USD-7,225,000USD-5,125,000USD
    Capital Expenditures-1,876,000USD-654,000USD-346,000USD-540,000USD-369,000USD-640,000USD-577,000USD-190,000USD
    Free Cash Flow-46,686,000USD-23,311,000USD-22,107,000USD-21,974,000USD-15,815,000USD-14,266,000USD-7,802,000USD-5,315,000USD
    Total Cashflows From Investing Activities78,559,000USD-474,000USD14,208,000USD-540,000USD-369,000USD-640,000USD-577,000USD-190,000USD
    Net Borrowings-23,064,000USD-2,000,000USD-1,955,000USD1,622,000USD-4,529,000USD6,981,000USD6,726,000USD—
    Total Cash From Financing Activities-10,638,000USD17,094,000USD9,840,000USD8,535,000USD6,711,000USD51,208,000USD7,979,000USD6,989,000USD
    Issuance Of Capital Stock13,795,000USD12,390,000USD10,085,000USD10,406,000USD13,961,000USD46,465,000USD2,284,000USD—
    Change In Cash23,111,000USD-6,037,000USD2,287,000USD-13,439,000USD-9,104,000USD36,942,000USD177,000USD1,674,000USD
    Begin Period Cash Flow13,239,000USD19,276,000USD16,989,000USD30,428,000USD39,532,000USD2,590,000USD2,413,000USD739,000USD
    End Period Cash Flow36,350,000USD13,239,000USD19,276,000USD16,989,000USD30,428,000USD39,532,000USD2,590,000USD2,413,000USD
    Other Cashflows From Investing Activities78,559,000USD180,000USD14,554,000USD—————
    Other Cashflows From Financing Activities-1,481,000USD20,282,000USD11,827,000USD-3,176,000USD-2,513,000USD1,203,000USD1,253,000USD20,497,000USD
    Unclassified Investing Cash Flow1,876,000USD—-14,208,000USD—————
    Investments—-474,000USD14,208,000USD-540,000USD-369,000USD-640,000USD-577,000USD—
    Sale Purchase Of Stock—-1,188,000USD-32,000USD—————
    Change To Liabilities———5,022,000USD-800,000USD1,651,000USD-333,000USD—
    Unclassified Financing Cash Flow—————-3,441,000USD-2,284,000USD-13,508,000USD
    Unclassified Operating Cash Flow———————-7,760,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31SegmentCardiovascular1,025,000USD0001104659-26-062634
    Q1 2026Quarterly · 2026-03-31SegmentWomen SHealth2,089,000USD0001104659-26-062634
    FY 2025Yearly · 2025-12-31SegmentCardiovascular3,155,000USD0001104659-26-027664
    FY 2025Yearly · 2025-12-31SegmentWomen SHealth9,138,000USD0001104659-26-027664
    Q3 2025Quarterly · 2025-09-30SegmentCardiovascular944,000USD0001104659-25-110492
    Q3 2025Quarterly · 2025-09-30SegmentWomen SHealth2,379,000USD0001104659-25-110492
    Q2 2025Quarterly · 2025-06-30SegmentCardiovascular736,000USD0001558370-25-011590
    Q2 2025Quarterly · 2025-06-30SegmentDevice Protection3,516,000USD0001558370-25-011590
    Q2 2025Quarterly · 2025-06-30SegmentWomen SHealth2,011,000USD0001558370-25-011590
    Q1 2025Quarterly · 2025-03-31SegmentCardiovascular326,000USD0001104659-26-062634
    Q1 2025Quarterly · 2025-03-31SegmentWomen SHealth2,625,000USD0001104659-26-062634
    FY 2024Yearly · 2024-12-31SegmentCardiovascular2,914,000USD0001104659-26-027664
    FY 2024Yearly · 2024-12-31SegmentWomen SHealth11,553,000USD0001104659-26-027664
    Q3 2024Quarterly · 2024-09-30SegmentCardiovascular562,000USD0001104659-25-110492
    Q3 2024Quarterly · 2024-09-30SegmentWomen SHealth3,100,000USD0001104659-25-110492
    Q3 2024Quarterly · 2024-09-30ProductCardiovascular562,000USD0001558370-24-015748
    Q3 2024Quarterly · 2024-09-30ProductDevice Protection2,260,000USD0001558370-24-015748
    Q3 2024Quarterly · 2024-09-30ProductWomen SHealth3,100,000USD0001558370-24-015748
    Q2 2024Quarterly · 2024-06-30SegmentCardiovascular1,081,000USD0001558370-25-011590
    Q2 2024Quarterly · 2024-06-30SegmentDevice Protection2,639,000USD0001558370-25-011590
    Q2 2024Quarterly · 2024-06-30SegmentWomen SHealth2,571,000USD0001558370-25-011590
    Q2 2024Quarterly · 2024-06-30ProductCardiovascular1,081,000USD0001558370-24-011988
    Q2 2024Quarterly · 2024-06-30ProductDevice Protection2,639,000USD0001558370-24-011988
    Q2 2024Quarterly · 2024-06-30ProductWomen SHealth2,571,000USD0001558370-24-011988
    Q1 2024Quarterly · 2024-03-31SegmentCardiovascular770,000USD0001558370-25-007586
    Q1 2024Quarterly · 2024-03-31SegmentDevice Protection2,357,000USD0001558370-25-007586
    Q1 2024Quarterly · 2024-03-31SegmentWomen SHealth3,567,000USD0001558370-25-007586
    Q1 2024Quarterly · 2024-03-31ProductCardiovascular770,000USD0001558370-24-007987
    Q1 2024Quarterly · 2024-03-31ProductDevice Protection2,357,000USD0001558370-24-007987
    Q1 2024Quarterly · 2024-03-31ProductWomen SHealth3,567,000USD0001558370-24-007987
    FY 2023Yearly · 2023-12-31SegmentCardiovascular5,040,000USD0001558370-25-002719
    FY 2023Yearly · 2023-12-31SegmentDevice Protection9,401,000USD0001558370-25-002719
    FY 2023Yearly · 2023-12-31SegmentWomen SHealth10,304,000USD0001558370-25-002719
    Q4 2023Quarterly · 2023-12-31ProductCardiovascular625,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31ProductDevice Protection2,255,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31ProductWomen SHealth2,995,000USDLegacy provider
    FY 2023Yearly · 2023-12-31ProductCardiovascular5,040,000USD0001558370-24-002864
    FY 2023Yearly · 2023-12-31ProductDevice Protection9,401,000USD0001558370-24-002864
    FY 2023Yearly · 2023-12-31ProductWomen SHealth10,304,000USD0001558370-24-002864
    Q3 2023Quarterly · 2023-09-30ProductCardiovascular938,000USD0001558370-24-015748
    Q3 2023Quarterly · 2023-09-30ProductDevice Protection2,575,000USD0001558370-24-015748
    Q3 2023Quarterly · 2023-09-30ProductWomen SHealth2,614,000USD0001558370-24-015748
    Q2 2023Quarterly · 2023-06-30ProductCardiovascular1,730,000USD0001558370-24-011988
    Q2 2023Quarterly · 2023-06-30ProductDevice Protection2,221,000USD0001558370-24-011988
    Q2 2023Quarterly · 2023-06-30ProductWomen SHealth2,400,000USD0001558370-24-011988
    Q1 2023Quarterly · 2023-03-31ProductCardiovascular1,747,000USD0001558370-24-007987
    Q1 2023Quarterly · 2023-03-31ProductDevice Protection2,350,000USD0001558370-24-007987
    Q1 2023Quarterly · 2023-03-31ProductWomen SHealth2,295,000USD0001558370-24-007987
    FY 2022Yearly · 2022-12-31ProductCardiovascular7,282,000USD0001558370-24-002864
    FY 2022Yearly · 2022-12-31ProductDevice Protection9,093,000USD0001558370-24-002864
    FY 2022Yearly · 2022-12-31ProductWomen SHealth7,474,000USD0001558370-24-002864
    Q3 2022Quarterly · 2022-09-30ProductCardiovascular1,718,000USD0001558370-23-019057
    Q3 2022Quarterly · 2022-09-30ProductDevice Protection2,319,000USD0001558370-23-019057
    Q3 2022Quarterly · 2022-09-30ProductWomen SHealth1,812,000USD0001558370-23-019057
    FY 2021Yearly · 2021-12-31ProductCardiovascular7,508,000USD0001558370-23-004475
    FY 2021Yearly · 2021-12-31ProductDevice Protection7,902,000USD0001558370-23-004475
    FY 2021Yearly · 2021-12-31ProductOrthobiologics26,934,000USD0001558370-23-004475
    FY 2021Yearly · 2021-12-31ProductWomen SHealth5,046,000USD0001558370-23-004475

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.